Displaying 61 - 72 of 114
Metabolism, Alcohol & Toxicity
Introduction

Introduction

Webcasts
View
Metabolism, Alcohol & Toxicity
Targeting obesity as a metabolic treatment approach in NAFLD/NASH

Targeting obesity as a metabolic treatment approach in NAFLD/NASH

Webcasts
View
Metabolism, Alcohol & Toxicity
Treatment strategies for improvement of NAFLD/NASH

Treatment strategies for improvement of NAFLD/NASH

Webcasts
View
Metabolism, Alcohol & Toxicity
Live discussion

Live discussion

Webcasts
View
Metabolism, Alcohol & Toxicity
The contribution of metabolic co-morbidities and hepatic thyroid hormone dysregulation to the pathophysiology of NASH

The contribution of metabolic co-morbidities and hepatic thyroid hormone dysregulation to the pathophysiology of NASH

Webcasts
View
Cirrhosis & Complications
Modulating systemic inflammation: how does Albumin work?

Modulating systemic inflammation: how does Albumin work?

Webcasts
View
Cirrhosis & Complications
How do patients benefit from Albumin?

How do patients benefit from Albumin?

Webcasts
View
Cirrhosis & Complications
Summary and Conclusions “from a fluid to a  medicine”

Summary and Conclusions “from a fluid to a  medicine”

Webcasts
View
Cirrhosis & Complications
The effective albumin concentration: from hypothesis to reality

The effective albumin concentration: from hypothesis to reality

Webcasts
View
Cirrhosis & Complications
Welcome and Introduction

Welcome and Introduction

Webcasts
View
Cirrhosis & Complications
When Platelet Count Matters: Prophylaxis Ahead of Procedures in Chronic Liver Disease Patients (CLD)

When Platelet Count Matters: Prophylaxis Ahead of Procedures in Chronic Liver Disease Patients (CLD)

Webcasts
View
Metabolism, Alcohol & Toxicity
NASH: An evolution in treatment response tools

NASH: An evolution in treatment response tools

Webcasts
View
Displaying 61 - 72 of 114